Cross Country Healthcare Files 8-K

TL;DR

CCH files 8-K, details TBD.

AI Summary

Cross Country Healthcare, Inc. filed an 8-K on September 3, 2025, reporting an "Other Event." The filing does not contain specific details about the event, dollar amounts, or definitive dates beyond the filing date itself.

Why It Matters

This filing indicates a significant event has occurred for Cross Country Healthcare, Inc., though the specific nature and impact are not yet disclosed.

Risk Assessment

Risk Level: medium — The filing is an 8-K 'Other Event,' which can range from minor administrative changes to significant corporate developments, making the immediate risk assessment uncertain without further details.

Key Players & Entities

• Cross Country Healthcare, Inc. (company) — Registrant
• September 3, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• Boca Raton, FL (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share CCRN NASDAQ Stock Market LL

Filing Documents

• dp233920_8k.htm (8-K) — 36KB
• 0000950103-25-011190.txt ( ) — 199KB
• ccrn-20250903.xsd (EX-101.SCH) — 3KB
• ccrn-20250903_lab.xml (EX-101.LAB) — 33KB
• ccrn-20250903_pre.xml (EX-101.PRE) — 22KB
• dp233920_8k_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events On September 3, 2025, in accordance with the terms of the Agreement and Plan of Merger, dated as of December 3, 2024 (as may be amended from time to time by the parties thereto, the " Merger Agreement "), among Cross Country Healthcare, Inc. (the " Company "), Aya Holdings II Inc. (" Parent "), Spark Merger Sub One Inc., a wholly owned subsidiary of Parent (" Merger Sub "), and, solely for the limited purposes set forth therein, Aya Healthcare, Inc., pursuant to which Merger Sub will merge with and into the Company (the " Merger "), the End Date (as defined in the Merger Agreement) was automatically extended from September 3, 2025 to December 3, 2025. Other than the extension of the End Date, the terms of the Merger Agreement remain unchanged. The foregoing description of the Merger Agreement is subject to, and is qualified in its entirety by, the full text of the Merger Agreement, which is filed as Annex A to the Definitive Proxy Statement filed by the Company on January 22, 2025, and which is incorporated herein by reference. As previously disclosed, the Company and Aya each previously received a request for additional information (the " Second Request ") from the U.S. Federal Trade Commission (the " FTC ") in connection with the FTC's review of the transactions contemplated by the Merger Agreement. As of August 29, 2025, each of the Company and Aya has certified to the FTC that it has substantially complied with the Second Request. Subject to the satisfaction or waiver of customary closing conditions, including receipt of certain regulatory approvals, the Merger is expected to close in the fourth quarter of 2025.

Forward-Looking Statements

Forward-Looking Statements This communication contains "forward-looking not statements of historical fact, including statements regarding the Merger; the expected timing and closing of the proposed Merger; the Company's ability to consummate the proposed Merger; the expected benefits of the proposed Merger; and other considerations taken into account by the board of directors of the Company in approving the proposed Merger; the amounts to be received by stockholders and expectations for the Company prior to and following the closing of the proposed Merger, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management's current expectations for the future of the Company based on current expectations and assumptions relating to the Company's business, the economy and other future conditions. Forward-looking "should," "will," "plans," "projects," "expects," "expectations," "estimates," "forecasts," "predicts," "targets," "prospects," "strategy," "signs," and other words of similar meaning in connection with the discussion of future performance, plans, actions or events. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others: (i) the timing to consummate the proposed Merger, (ii) the risk that a condition of closing of the proposed Merger may not be satisfied or that the closing of the proposed Merger might otherwise not occur, (iii) the risk that a regulatory approval that may be required for the proposed Merger is not obtained or is obtained subject to conditions that are not anticipated, (iv) the diversion of managemen

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CROSS COUNTRY HEALTHCARE, INC. Date: September 3, 2025 By: /s/ John Martins Name: John Martins Title: President & Chief Executive Officer (Principal Executive Officer)

View Full Filing

View this 8-K filing on SEC EDGAR